Esperion Therapeutics, Inc.

NASDAQ (USD): Esperion Therapeutics, Inc. (ESPR)

Last Price

2.46

Today's Change

+0.13 (5.57%)

Day's Change

2.35 - 2.54

Trading Volume

7,459,533

Overview

Market Cap

484 Million

Shares Outstanding

197 Million

Avg Volume

5,473,784

Avg Price (50 Days)

2.39

Avg Price (200 Days)

2.24

PE Ratio

-3.57

EPS

-0.69

Earnings Announcement

25-Feb-2025

Previous Close

2.33

Open

2.43

Day's Range

2.35 - 2.5399

Year Range

1.58 - 3.94

Trading Volume

7,459,533

Price Change Highlight

1 Day Change

5.58%

5 Day Change

12.84%

1 Month Change

14.42%

3 Month Change

41.38%

6 Month Change

-9.56%

Ytd Change

-15.75%

1 Year Change

16.59%

3 Year Change

-52.33%

5 Year Change

-95.33%

10 Year Change

-93.23%

Max Change

-83.03%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment